Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Melanoma Research|April 11, 2023
Feasibility of personalized circulating tumor DNA detection in stage II and III melanomaElise K Brunsgaard, Tawnya L Bowles, Elliot A Asare, et al.
Journal for Immunotherapy of Cancer|December 23, 2022
Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI studyBrendan D Curti, Jon Richards, John R Hyngstrom, et al.
Melanoma Research|June 12, 2013
Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanomaJohn R Hyngstrom, Yi-Ju Chiang, Kate D Cromwell, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 8, 2014
Cardiac, skeletal, and smooth muscle mitochondrial respiration: are all mitochondria created equal?Song-Young Park, Jayson R Gifford, Robert H I Andtbacka, et al.
Journal of Surgical Oncology|February 11, 2014
Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experienceJohn R Hyngstrom, Ching-Wei D Tzeng, Sam Beddar, et al.
Melanoma Research|June 21, 2019
Recurrence risk of early-stage melanoma of the external ear: an investigation of surgical approach and sentinel lymph node statusAmanda Truong, John R Hyngstrom, Robert H I Andtbacka, et al.
Oncotarget|July 9, 2016
A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanomaAbhijit Ray, Matthew A Williams, Stephanie M Meek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Phase 1 and 2 Clinical Studies of the STING Agonist Ulevostinag With and Without Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors or LymphomasKevin J Harrington, Stephane Champiat, Joshua D Brody, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentEric A Smith, Rachel L Belote, Nelly M Cruz, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironmentEric A Smith, Rachel L Belote, Nelly M Cruz, et al.
Pageof 4